Back to UBS Group AG UBS Group AG

CMMBCMMB
4 quarters

Position history for UBS Group AGUBS Group AG's holdings in CHEMOMAB THERAPEUTICS LTD

UBS Group AG previously held 0 shares of CMMB (CHEMOMAB THERAPEUTICS LTD), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$260

Total Shares Change

-99

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$1.62
0
2026-Q1
Decreased
8
-99.6%
$130.0%$1.79
0
2025-Q4
Increased
2,253
+2175.8%
$3,7170.0%$1.64
15
2025-Q3
New
99
-
$2600.0%$2.65
17

Other major holders of CMMB: MORGAN STANLEY, CITADEL ADVISORS LLC, JANE STREET GROUP, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used